Consistent with these reports, VEGF levels fell in WT mice after 15 days of L-NAME treatment and the resulting sustained hypertension (Fig. 3C–F; the decrease was highly significant in the lung (P = 0.0002) and almost achieved significance (p = 0.069) in the heart). This evidence concerns the gene VEGFA and hypertensive disorder.